Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Net Income | -39.64% | -16.63% | 81.42% | -195.99% | -65.52% |
| Total Depreciation and Amortization | -0.70% | -0.61% | -1.11% | -0.68% | -0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.35% | 690.78% | -98.49% | 1,787.94% | 39.52% |
| Change in Net Operating Assets | 317.10% | -34.82% | -51.19% | 53.46% | 506.93% |
| Cash from Operations | 44.93% | 29.74% | 9.55% | 52.93% | -3.03% |
| Capital Expenditure | -- | -- | 100.00% | 6.25% | 77.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | 149.23% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | 90.63% | -- | -100.00% | 735.37% | -13.89% |
| Total Debt Issued | -34.61% | -12.20% | 15.43% | -62.69% | 6.22% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -34.61% | -12.20% | 15.43% | -62.69% | 6.22% |
| Foreign Exchange rate Adjustments | -15.30% | -815.09% | 167.09% | 74.27% | -62.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,200.00% | 94.34% | 84.08% | 53.23% | 6.44% |